ヘモグロビン検査市場：タイプ、技術、操作、用途、エンドユーザー別-2025～2030年の世界予測

ヘモグロビン検査市場は、2023年に57億米ドルと評価され、2024年には60億4,000万米ドルに達すると予測され、CAGR 6.10%で成長し、2030年には86億3,000万米ドルに達すると予測されています。

ヘモグロビン検査は、主に血液中のヘモグロビン量を測定し、貧血を診断し、糖尿病などの慢性疾患の治療効果をモニタリングするために使用される、医療産業における不可欠な診断手順です。ヘモグロビン検査の必要性は、重要な健康情報を提供し、様々な医療専門セグメントの患者管理の意思決定に影響を与えるという役割に起因しています。日常的な健康診断から、内科、小児科、血液内科などの専門的な医療現場まで、その用途は広がっており、最終用途は病院、診断ラボ、在宅医療の現場が中心となっています。ヘモグロビン検査市場に影響を与える主要成長要因としては、血液疾患の有病率の増加、高齢者の増加、ポイントオブケア検査技術の進歩などが挙げられます。また、個別化医療への注目の高まりや、医療に対する意識の高まりと積極的な取り組みといった動向も、市場の拡大を後押ししています。非侵襲的で迅速な検査法の開発、データアクセシビリティを高めるためのデジタルヘルスプラットフォームとの統合、医療インフラが急速に発展している新興国市場への進出などが、市場開拓の機会となります。しかし、先進的な診断機器に関連する高額なコストや、医療サービスへのアクセスの世界のばらつきといった限界に直面し、成長の可能性を阻む可能性があります。また、厳しい規制要件が新規参入障壁となる可能性もあります。イノベーションは、精度の向上、患者の不快感の軽減、非専門家環境向けの使いやすいアプリケーションの強化など、検査手順の進歩に焦点を当てることで推進できます。また、AIとビッグデータ分析を導入して診断洞察と患者の転帰を改善することも、大幅な改善につながる可能性があります。全体として、ヘモグロビン検査市場はダイナミックな成長の可能性を示しているが、規制状況を戦略的にナビゲートし、機会を最大化するための技術革新への投資が必要です。

市場力学：急速に進化するヘモグロビン検査市場の主要市場洞察を公開

ヘモグロビン検査市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患の流行と定期的なヘモグロビン値モニタリングの必要性
  • 改良された使いやすいポイントオブケア検査の利用可能性
  • 貧血検査に対する認識を促進する政府の取り組み
• 市場抑制要因
  • 検査方法の複雑さと専門的スキルの必要性
• 市場機会
  • ヘモグロビン検査法の技術的進歩
  • 高性能な家庭用ヘモグロビン検査キットとデバイスの採用
• 市場課題
  • 不正確さや偽陽性に関する懸念

ポーターのファイブフォース：ヘモグロビン検査市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、ヘモグロビン検査市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ヘモグロビン検査市場における外部からの影響の把握

外部マクロ環境要因は、ヘモグロビン検査市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：ヘモグロビン検査市場における競合情勢の把握

ヘモグロビン検査市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：ヘモグロビン検査市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ヘモグロビン検査市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：ヘモグロビン検査市場における成功への道筋を描く

ヘモグロビン検査市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の蔓延と定期的なヘモグロビン濃度モニタリングの必要性
    • 改善されたユーザーフレンドリーなポイントオブケア検査の提供
    • 貧血検査に関する意識を高める政府の取り組み
  • 抑制要因
    • 特定のテスト方法の複雑さと専門的なスキルの必要性
  • 機会
    • ヘモグロビン検査方式の技術的進歩
    • 高性能なホームキットとデバイスの採用
  • 課題
    • 不正確さと誤検出に関する懸念
• 市場セグメンテーション分析
  • タイプ：総ヘモグロビン濃度を測定するための標準的かつ費用対効果の高い技術としてのシアンメトヘモグロビン法の使用
  • 操作：利便性と採血に伴う不快感を軽減できるため、非侵襲的ヘモグロビン検査が好まれる
  • 用途：貧血の重症度を判断するための先進的ヘモグロビン検査ソリューション
  • エンドユーザー：さまざまな血液疾患を診断するための多様なヘモグロビン検査の利用可能性
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 ヘモグロビン検査市場：タイプ別

• イントロダクション
• 血糖値検査
• シアンメトヘモグロビン法
• ヘモグロビン電気泳動

第7章 ヘモグロビン検査市場：技術別

• イントロダクション
• 臨床検査
• ポイントオブケア検査

第8章 ヘモグロビン検査市場：操作別

• イントロダクション
• 侵襲的検査
  • 侵襲性キュベット
  • 侵略的ストリップ
• 非侵襲的検査

第9章 ヘモグロビン検査市場：用途別

• イントロダクション
• 貧血の診断とモニタリング
• 糖尿病の診断と管理
• 鎌状赤血球症のスクリーニング
• サラセミアの検出

第10章 ヘモグロビン検査市場：エンドユーザー別

• イントロダクション
• 血液バンク
• 診断ラボ
• 在宅医療
• 病院・クリニック
• 研究機関

第11章 南北アメリカのヘモグロビン検査市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋のヘモグロビン検査市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカのヘモグロビン検査市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • Sanguina、ヘモグロビン検査キットで米国FDAの認可を取得
  • Mylabが独自のポイントオブケア鎌状赤血球貧血検査を導入
  • Hemex Health、米国市場向けガゼルHb変異検査の商業化を推進するため300万米ドルの助成金を獲得
• 戦略分析と提言

企業一覧

• Abcam PLC
• ACON Laboratories, Inc.
• AdvaCare Pharma
• Arkray, Inc.
• ARUP Laboratories
• Attikouris Enterprises Ltd.
• Avantor, Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Bio-Techne Corporation
• Boditech Med Inc.
• Clarity Diagnostics, LLC
• Cliawaived, Inc.
• DiaSys Diagnostic Systems GmbH
• EKF Diagnostics Holdings PLC by IBL PLC
• F. Hoffmann-La Roche AG
• HemoCue AB
• Laboratory Corporation of America Holdings
• Masimo Corp.
• Merck KGaA
• Nova Biomedical
• OrSense Ltd.
• PerkinElmer Inc.
• Qiagen N.V.
• Quest Diagnostics Incorporated
• Siemens Healthcare GmbH
• Sotera Health Company
• Thermo Fisher Scientific Inc.
• Versiti, Inc.
• VivaChek BIoTech（Hangzhou）Co., Ltd.

LIST OF FIGURES

• FIGURE 1. HEMOGLOBIN TESTING MARKET RESEARCH PROCESS
• FIGURE 2. HEMOGLOBIN TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. HEMOGLOBIN TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. HEMOGLOBIN TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. HEMOGLOBIN TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. HEMOGLOBIN TESTING MARKET DYNAMICS
• TABLE 7. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY BLOOD GLUCOSE TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY CYANMETHEMOGLOBIN METHOD, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY HEMOGLOBIN ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE CUVETTE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE STRIP, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY NON-INVASIVE TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY ANEMIA DIAGNOSIS & MONITORING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY DIABETES DIAGNOSIS & MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY SICKLE CELL DISEASE SCREENING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY THALASSEMIA DETECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY BLOOD BANK, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL HEMOGLOBIN TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. CANADA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. CANADA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 52. CANADA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 53. CANADA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 54. CANADA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. CANADA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES HEMOGLOBIN TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 80. AUSTRALIA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. AUSTRALIA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. CHINA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. CHINA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 84. CHINA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 85. CHINA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 86. CHINA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. CHINA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. INDIA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. INDIA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 90. INDIA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 91. INDIA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 92. INDIA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. INDIA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. INDONESIA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. INDONESIA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 96. INDONESIA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 97. INDONESIA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 98. INDONESIA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. INDONESIA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. JAPAN HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. JAPAN HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 102. JAPAN HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 103. JAPAN HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 104. JAPAN HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. JAPAN HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. MALAYSIA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. MALAYSIA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 108. MALAYSIA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 109. MALAYSIA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 110. MALAYSIA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. MALAYSIA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. PHILIPPINES HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. PHILIPPINES HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 114. PHILIPPINES HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 115. PHILIPPINES HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 116. PHILIPPINES HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. PHILIPPINES HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. SINGAPORE HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. SINGAPORE HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 120. SINGAPORE HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 121. SINGAPORE HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 122. SINGAPORE HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. SINGAPORE HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH KOREA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH KOREA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH KOREA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. TAIWAN HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 131. TAIWAN HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 132. TAIWAN HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 133. TAIWAN HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 134. TAIWAN HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. TAIWAN HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. THAILAND HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 137. THAILAND HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 138. THAILAND HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 139. THAILAND HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 140. THAILAND HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. THAILAND HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. VIETNAM HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. VIETNAM HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 144. VIETNAM HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 145. VIETNAM HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 146. VIETNAM HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. VIETNAM HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 148. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 155. DENMARK HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 156. DENMARK HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 157. DENMARK HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 158. DENMARK HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 159. DENMARK HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. DENMARK HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. EGYPT HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 162. EGYPT HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 163. EGYPT HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 164. EGYPT HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 165. EGYPT HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. EGYPT HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 167. FINLAND HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 168. FINLAND HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 169. FINLAND HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 170. FINLAND HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 171. FINLAND HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. FINLAND HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 173. FRANCE HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 174. FRANCE HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 175. FRANCE HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 176. FRANCE HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 177. FRANCE HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 178. FRANCE HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 179. GERMANY HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 180. GERMANY HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 181. GERMANY HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 182. GERMANY HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 183. GERMANY HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. GERMANY HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. ISRAEL HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 186. ISRAEL HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 187. ISRAEL HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 188. ISRAEL HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 189. ISRAEL HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. ISRAEL HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. ITALY HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 192. ITALY HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 193. ITALY HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 194. ITALY HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 195. ITALY HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 196. ITALY HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 197. NETHERLANDS HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 198. NETHERLANDS HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 199. NETHERLANDS HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 200. NETHERLANDS HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 201. NETHERLANDS HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 202. NETHERLANDS HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 203. NIGERIA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 204. NIGERIA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 205. NIGERIA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 206. NIGERIA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 207. NIGERIA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 208. NIGERIA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 209. NORWAY HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 210. NORWAY HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 211. NORWAY HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 212. NORWAY HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 213. NORWAY HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 214. NORWAY HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 215. POLAND HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 216. POLAND HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 217. POLAND HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 218. POLAND HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 219. POLAND HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 220. POLAND HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 221. QATAR HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 222. QATAR HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 223. QATAR HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 224. QATAR HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 225. QATAR HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 226. QATAR HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 227. RUSSIA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 228. RUSSIA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 229. RUSSIA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 230. RUSSIA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 231. RUSSIA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 232. RUSSIA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 233. SAUDI ARABIA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 234. SAUDI ARABIA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 236. SAUDI ARABIA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 238. SAUDI ARABIA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 239. SOUTH AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 244. SOUTH AFRICA HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 245. SPAIN HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 246. SPAIN HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 247. SPAIN HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 248. SPAIN HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 249. SPAIN HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 250. SPAIN HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 251. SWEDEN HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 252. SWEDEN HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 253. SWEDEN HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 254. SWEDEN HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 255. SWEDEN HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 256. SWEDEN HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 257. SWITZERLAND HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 258. SWITZERLAND HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 259. SWITZERLAND HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 260. SWITZERLAND HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 261. SWITZERLAND HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 262. SWITZERLAND HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 263. TURKEY HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 264. TURKEY HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 265. TURKEY HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 266. TURKEY HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 267. TURKEY HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 268. TURKEY HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 269. UNITED ARAB EMIRATES HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 270. UNITED ARAB EMIRATES HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 275. UNITED KINGDOM HEMOGLOBIN TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 276. UNITED KINGDOM HEMOGLOBIN TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM HEMOGLOBIN TESTING MARKET SIZE, BY OPERATION, 2018-2030 (USD MILLION)
• TABLE 278. UNITED KINGDOM HEMOGLOBIN TESTING MARKET SIZE, BY INVASIVE TESTING, 2018-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM HEMOGLOBIN TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 280. UNITED KINGDOM HEMOGLOBIN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 281. HEMOGLOBIN TESTING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 282. HEMOGLOBIN TESTING MARKET, FPNV POSITIONING MATRIX, 2023

The Hemoglobin Testing Market was valued at USD 5.70 billion in 2023, expected to reach USD 6.04 billion in 2024, and is projected to grow at a CAGR of 6.10%, to USD 8.63 billion by 2030.

Hemoglobin testing is an essential diagnostic procedure within the healthcare industry, primarily used to measure the amount of hemoglobin in blood, diagnose anemia, and monitor treatment efficacy in chronic conditions like diabetes. The necessity for hemoglobin testing stems from its role in providing critical health information, influencing patient management decisions across various medical specialties. Applications extend from routine health check-ups to specialized care settings, spanning areas like internal medicine, pediatrics, and hematology, with end-use predominant among hospitals, diagnostic laboratories, and homecare settings. Key growth factors impacting the hemoglobin testing market include an increasing prevalence of blood disorders, growing geriatric population, and advances in point-of-care testing technology. Additionally, trends such as the heightened focus on personalized medicine, and the rise in awareness and proactive healthcare practices are propelling market expansion. Opportunities can be seized in the development of non-invasive and rapid testing methods, integration with digital health platforms for enhanced data accessibility, and expansion into emerging markets where healthcare infrastructure is evolving rapidly. However, the market faces limitations like high costs associated with advanced diagnostic equipment and varying access to healthcare services globally, which can stymie growth potential. Stringent regulatory requirements may also pose as barriers to market entry for new players. Innovation can be driven by focusing on advancements in testing procedures that improve accuracy, reduce patient discomfort, and enhance user-friendly applications for non-specialist environments. Embracing AI and big data analytics to improve diagnostic insights and patient outcomes can also lead to significant improvements. Overall, the hemoglobin testing market demonstrates dynamic growth potential, yet it necessitates strategic navigation through regulatory landscapes and investment in technological innovations to maximize opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Hemoglobin Testing Market

The Hemoglobin Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Prevalence of chronic diseases and need for regular hemoglobin level monitoring
  • Availability of improved and user-friendly point-of-care testing
  • Government initiatives promoting awareness about anemia testing
• Market Restraints
  • Complexity of certain testing methods and need for specialized skills
• Market Opportunities
  • Technological advancements in hemoglobin testing methods
  • Introduction of high-performing home hemoglobin testing kits and devices
• Market Challenges
  • Concerns associated with inaccuracy and false positives

Porter's Five Forces: A Strategic Tool for Navigating the Hemoglobin Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Hemoglobin Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Hemoglobin Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Hemoglobin Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Hemoglobin Testing Market

A detailed market share analysis in the Hemoglobin Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Hemoglobin Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Hemoglobin Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Hemoglobin Testing Market

A strategic analysis of the Hemoglobin Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Hemoglobin Testing Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, ACON Laboratories, Inc., AdvaCare Pharma, Arkray, Inc., ARUP Laboratories, Attikouris Enterprises Ltd., Avantor, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Boditech Med Inc., Clarity Diagnostics, LLC, Cliawaived, Inc., DiaSys Diagnostic Systems GmbH, EKF Diagnostics Holdings PLC by IBL PLC, F. Hoffmann-La Roche AG, HemoCue AB, Laboratory Corporation of America Holdings, Masimo Corp., Merck KGaA, Nova Biomedical, OrSense Ltd., PerkinElmer Inc., Qiagen N.V., Quest Diagnostics Incorporated, Siemens Healthcare GmbH, Sotera Health Company, Thermo Fisher Scientific Inc., Versiti, Inc., and VivaChek Biotech (Hangzhou) Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Hemoglobin Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Blood Glucose Testing, Cyanmethemoglobin Method, and Hemoglobin Electrophoresis.
• Based on Technology, market is studied across Laboratory Testing and Point-of-Care Testing.
• Based on Operation, market is studied across Invasive Testing and Non-Invasive Testing. The Invasive Testing is further studied across Invasive Cuvette and Invasive Strip.
• Based on Application, market is studied across Anemia Diagnosis & Monitoring, Diabetes Diagnosis & Management, Sickle Cell Disease Screening, and Thalassemia Detection.
• Based on End-User, market is studied across Blood Bank, Diagnostic Laboratories, Homecare Settings, Hospitals & Clinics, and Research Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of chronic diseases and need for regular hemoglobin level monitoring
    • 5.1.1.2. Availability of improved and user-friendly point-of-care testing
    • 5.1.1.3. Government initiatives promoting awareness about anemia testing
  • 5.1.2. Restraints
    • 5.1.2.1. Complexity of certain testing methods and need for specialized skills
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in hemoglobin testing methods
    • 5.1.3.2. Introduction of high-performing home hemoglobin testing kits and devices
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns associated with inaccuracy and false positives
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Use of cyanmethemoglobin method as a standard and cost-effective technique for measuring total hemoglobin concentration
  • 5.2.2. Operation: Preference for non-invasive hemoglobin testing due to their convenience and ability to reduce discomfort associated with blood draws
  • 5.2.3. Application: Advanced hemoglobin testing solutions to determine the severity of anemia
  • 5.2.4. End-User: Availability of diverse range of hemoglobin testing to diagnose various hematological disorders
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Hemoglobin Testing Market, by Type

• 6.1. Introduction
• 6.2. Blood Glucose Testing
• 6.3. Cyanmethemoglobin Method
• 6.4. Hemoglobin Electrophoresis

7. Hemoglobin Testing Market, by Technology

• 7.1. Introduction
• 7.2. Laboratory Testing
• 7.3. Point-of-Care Testing

8. Hemoglobin Testing Market, by Operation

• 8.1. Introduction
• 8.2. Invasive Testing
  • 8.2.1. Invasive Cuvette
  • 8.2.2. Invasive Strip
• 8.3. Non-Invasive Testing

9. Hemoglobin Testing Market, by Application

• 9.1. Introduction
• 9.2. Anemia Diagnosis & Monitoring
• 9.3. Diabetes Diagnosis & Management
• 9.4. Sickle Cell Disease Screening
• 9.5. Thalassemia Detection

10. Hemoglobin Testing Market, by End-User

• 10.1. Introduction
• 10.2. Blood Bank
• 10.3. Diagnostic Laboratories
• 10.4. Homecare Settings
• 10.5. Hospitals & Clinics
• 10.6. Research Institutes

11. Americas Hemoglobin Testing Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Hemoglobin Testing Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Hemoglobin Testing Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Sanguina Receives US FDA Clearance for Haemoglobin Test Kit
  • 14.3.2. Mylab Introduces Indigenous Point-of-Care Sickle Cell Anaemia Test
  • 14.3.3. Hemex Health Awarded USD 3 Million Grant to Advance Commercialization of Gazelle Hb Variant Test for the U.S. market
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abcam PLC
• 2. ACON Laboratories, Inc.
• 3. AdvaCare Pharma
• 4. Arkray, Inc.
• 5. ARUP Laboratories
• 6. Attikouris Enterprises Ltd.
• 7. Avantor, Inc.
• 8. Becton, Dickinson and Company
• 9. Bio-Rad Laboratories, Inc.
• 10. Bio-Techne Corporation
• 11. Boditech Med Inc.
• 12. Clarity Diagnostics, LLC
• 13. Cliawaived, Inc.
• 14. DiaSys Diagnostic Systems GmbH
• 15. EKF Diagnostics Holdings PLC by IBL PLC
• 16. F. Hoffmann-La Roche AG
• 17. HemoCue AB
• 18. Laboratory Corporation of America Holdings
• 19. Masimo Corp.
• 20. Merck KGaA
• 21. Nova Biomedical
• 22. OrSense Ltd.
• 23. PerkinElmer Inc.
• 24. Qiagen N.V.
• 25. Quest Diagnostics Incorporated
• 26. Siemens Healthcare GmbH
• 27. Sotera Health Company
• 28. Thermo Fisher Scientific Inc.
• 29. Versiti, Inc.
• 30. VivaChek Biotech (Hangzhou) Co., Ltd.